Peptide foldamer-based inhibitors of the SARS-CoV-2 S protein-human ACE2 interaction

• Egile Nagusiak: Violeta Marković (Egilea), Jeelan Basha Shaik (Egilea), Katarzyna Ożga (Egilea), Agnieszka Ciesiołkiewicz (Egilea), Juan Lizandra Perez (Egilea), Ewa Rudzińska-Szostak (Egilea), Łukasz Berlicki (Egilea)
• Formatua: Liburua
• Argitaratua: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The entry of the SARS-CoV-2 virus into a human host cell begins with the interaction between the viral spike protein (S protein) and human angiotensin-converting enzyme 2 (hACE2). Therefore, a possible strategy for the treatment of this infection is based on inhibiting the interaction of the two abo...